Cargando…
Resistance of Renal Cell Carcinoma to Sorafenib Is Mediated by Potentially Reversible Gene Expression
PURPOSE: Resistance to antiangiogenic therapy is an important clinical problem. We examined whether resistance occurs at least in part via reversible, physiologic changes in the tumor, or results solely from stable genetic changes in resistant tumor cells. EXPERIMENTAL DESIGN: Mice bearing two human...
Autores principales: | Zhang, Liang, Bhasin, Manoj, Schor-Bardach, Rachel, Wang, Xiaoen, Collins, Michael P., Panka, David, Putheti, Prabhakar, Signoretti, Sabina, Alsop, David C., Libermann, Towia, Atkins, Michael B., Mier, James W., Goldberg, S. Nahum, Bhatt, Rupal S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084751/ https://www.ncbi.nlm.nih.gov/pubmed/21559452 http://dx.doi.org/10.1371/journal.pone.0019144 |
Ejemplares similares
-
High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma
por: Wang, Xiaoen, et al.
Publicado: (2011) -
Inhibition of ALK1 signaling with dalantercept combined with VEGFR TKI leads to tumor stasis in renal cell carcinoma
por: Wang, Xiaoen, et al.
Publicado: (2016) -
The Role of TNF-α in Mice with Type 1- and 2- Diabetes
por: Koulmanda, Maria, et al.
Publicado: (2012) -
The Role of Angiopoietins as Potential Therapeutic Targets in Renal Cell Carcinoma()
por: Wang, Xiaoen, et al.
Publicado: (2014) -
Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma
por: Liu, Qingjun, et al.
Publicado: (2011)